GaoC, XieR, RenC, YangX (2012) Dickkopf-1 expression is a novel prognostic marker for gastric cancer. J Biomed Biotechnol, 2012:804592.
2.
GomceliI, BostanciEB, OzerI, et al. (2012) A novel screening biomarker in gastric cancer: serum Dickkopf-1. Hepatogastroenterology, 59:1661-1664.
3.
GregoryCA, SinghH, PerryAS, ProckopDJ (2003) The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem, 278:28067-28078.
4.
LeeHS, LeeHE, Park doJ, et al. (2012) Clinical significance of serum and tissue Dickkopf-1 levels in patients with gastric cancer. Clin Chim Acta, 413:1753-1760.
5.
LiuQ-R, LiY-F, DengZ-Q, CaoJ-Q (2016) Prognostic significance of DKK1 in gastric cancer survival: a meta-analysis. Genet Test Mol Biomarkers, 20:170-175.
6.
MenezesME, DevineDJ, ShevdeLA, SamantRS (2012) Dickkopf1: a tumor suppressor or metastasis promoter?. Int J Cancer, 130:1477-1483.
7.
MukhopadhyayM, ShtromS, Rodriguez-EstebanC, et al. (2001) Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse. Dev Cell, 1:423-434.
8.
NiidaA, HirokoT, KasaiM, et al. (2004) DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene, 23:8520-8526.
9.
QiL, SunB, LiuZ, et al. (2012) Dickkopf-1 inhibits epithelial-mesenchymal transition of colon cancer cells and contributes to colon cancer suppression. Cancer Sci, 103:828-835.
10.
QianJ, XieJ, HongS, et al. (2007) Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma. Blood, 110:1587-1594.
11.
RaoTP, KuhlM (2010) An updated overview on Wnt signaling pathways. Circ Res, 106:1798-1806.
12.
SatoN, YamabukiT, TakanoA, et al. (2010) Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy. Cancer Res, 70:5326-5336.
13.
SemënovMV, ZhangX, HeX (2008) DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation. J Biol Chem, 283:21427-21432.
14.
XuH, WuJ, ChenB, et al. (2014) Serum Dickkopf-1 (DKK1) is significantly lower in patients with lung cancer but is rapidly normalized after treatment. Am J Transl Res, 6:850-856.
15.
XuWH, LiuZB, YangC, et al. (2012) Expression of dickkopf-1 and beta-catenin related to the prognosis of breast cancer patients with triple negative phenotype. PLoS One, 7:e37624.
16.
YaccobyS, LingW, ZhanF, et al. (2007) Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo. Blood, 109:2106-2111.
